Ramesh Swaminathan, Global CFO of Lupin discusses the impact of Trump's win on the Indian pharmaceutical sector. Growing demand for affordable medicines, and diversification from China are key factors benefitting his company. He also talks about R&D and productivity as drivers to further increase margins.
Lupin Global CFO: Medicine business benefitting from supply chain diversification
6 hours ago
Ramesh Swaminathan, Global CFO of Lupin discusses the impact of Trump's win on the Indian pharmaceutical sector. Growing demand for affordable medicines, and diversification from China are key factors benefitting his company. He also talks about R&D and productivity as drivers to further increase margins.
Related
Popular
First cloned ferret gives birth shorts
10 hours ago
